Back to search

Sweden· SE-20150312000039

Amlodipine/Valsartan Mylan 5 mg/160 mg Filmdragerad tablett

A medicinal product containing valsartan + amlodipine, registered in Sweden by Mylan Pharmaceuticals Limited.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedAmlodipine/Valsartan Mylan 5 mg/160 m…ATC—REGISTER NO.SE-20150312000039PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Valsartan + Amlodipine
Manufacturer
Mylan Pharmaceuticals Limited
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20150312000039

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Valsartan + amlodipine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valsartan + amlodipine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Amlodipin/Valsartan +pharma, Amlodipin/Valsartan 1a Pharma
  • Belgium · Amlodipine/Valsartan Eg, Amlodipine/Valsartan Krka
  • Bulgaria · Aзбима, Валдипин Дуо
  • Cyprus · Valsimia
  • Czechia · Asbima, Wamlox
  • Germany · Amlo-Valsacor, Amlodipin Hexal Plus Valsartan Hexal
  • Denmark · Amlodipin/Valsartan Stada
  • Estonia · Wamlox
  • Spain · Amlodipino/Valsartán Aurovitas, Amlodipino/Valsartán Cinfamed
  • Finland · Amlodipin/Valsartan Krka, Amlodipin/Valsartan Orion
  • France · Amlodipine/Valsartan Accord, Amlodipine/Valsartan Arrow
  • United Kingdom (Northern Ireland) · Amlodipine / Valsartan Zentiva Pharma
  • Greece · Alvoda, Amlodipine+valsartan Tad
  • Croatia · Dipperam, Vainas
  • Hungary · Amlodipin/Valsartan Krka Pharma, Amlodipin/Valsartan Sandoz
  • Ireland · Amlodipine/Valsartan Clonmel, Amlodipine/Valsartan Krka
  • Iceland · Amlodipine/Valsartan Mylan, Copalia
  • Italy · Amlodipina E Valsartan Doc, Amlodipina E Valsartan Krka Pharma
  • Liechtenstein · Amlodipine/Valsartan Mylan, Copalia
  • Lithuania · Amlodipine/Valsartan Ingen Pharma, Dipperam
  • Luxembourg · Amlodipine/Valsartan Eg
  • Latvia · Wamlox
  • Netherlands · Amlodipine Besylate/Valsartan Aurobindo, Amlodipine/Valsartan Sandoz
  • Norway · Amlodipin/Valsartan Krka, Amlodipine/Valsartan Mylan
  • Poland · Avasart Plus, Dipperam
  • Portugal · Amlodipina / Valsartan Macleods, Amlodipina + Valsartan Alter
  • Romania · Amlodipină/Valsartan Stada, Bevacomb
  • Slovenia · Wamlox
  • Slovakia · Amlodipín/Valsartan Sandoz, Wamlox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bca88022-9807-43b3-ba89-d04c624bc6cb
GET /v1/drugs/bca88022-9807-43b3-ba89-d04c624bc6cb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20150312000039",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150312000039",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/amlodipine/valsartan-mylan-epar-product-information_sv.pdf"
}

See everything about valsartan + amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.